Filana Therapeutics
FLNA · NASDAQ
$0.6885+$0.0065 (+0.95%)TodayMarket closed ·
Prev close $0.682
Who owns FLNA
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 21.1% of FLNA’s shares.
- Vanguard Capital Management, LLC4.1%
- Two Sigma Investments, LP3.5%
- Marshall Wace LLP3.3%
- BlackRock Institutional Trust Company, N.A.3.0%
- Next 6 largest institutions7.2%
- All other shareholders78.9%
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Capital Management, LLC | 1.97M | 4.09% |
| Two Sigma Investments, LP | 1.71M | 3.54% |
| Marshall Wace LLP | 1.60M | 3.31% |
| BlackRock Institutional Trust Company, N.A. | 1.44M | 2.98% |
| Barry (Richard J) | 938.06K | 1.94% |
| Geode Capital Management, L.L.C. | 615.51K | 1.27% |
| Goldman Sachs & Co. LLC | 603.18K | 1.25% |
| D. E. Shaw & Co., L.P. | 485.02K | 1.00% |
| GMT Capital Corp. | 450.10K | 0.93% |
| Renaissance Technologies LLC | 389.60K | 0.81% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.37M | 2.83% |
| Vanguard Extended Market Index Fund | 563.88K | 1.17% |
| Fidelity Extended Market Index Fund | 254.14K | 0.53% |
| iShares Micro-Cap ETF | 150.55K | 0.31% |
| Vanguard Health Care Index Fund | 133.60K | 0.28% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $278.13K (2 trades) of FLNA on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Barry Richard | Buy | 100.00K | $92.00K |
| Barry Richard | Buy | 206.81K | $186.13K |
Short interest
Settled Sep 30, 2026
- Shares short
- 5.89M
- Days to cover
- 1.00
- % of shares outstanding
- 12.18%
- Average daily volume
- 9.67M
- Change since last report
- −5.3%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.